Korea Food Research Institute, Gyeonggi, Republic of Korea.
Int Immunopharmacol. 2013 Oct;17(2):191-7. doi: 10.1016/j.intimp.2013.06.013. Epub 2013 Jun 28.
Many natural resources obtained from plants have been studied for their utility as host defense potentiators. In the present study, we investigated whether a glycoprotein fraction from rice (Oryza sativa) bran (GFRB) could modulate immune responses such as the production of nitric oxide (NO), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-10 in the RAW 264.7 macrophage cell line. GFRB, which contained 65.7% of protein and 7.7% of total sugar, was prepared by treating an aqueous extract of rice bran with 80% (NH4)2SO4 and the extraction yield was 4.9%. GFRB consisted of 5 bands with varying molecular weights by SDS-PAGE and remarkably improved production of NO in RAW 264.7 murine macrophage cells, up to approximately 10-fold compared to the normal control at 100μg/mL concentration. In RAW 264.7 cells treated with 50μg/mL GFRB, released levels of various cytokines such as TNF-α, IL-1β, IL-6, and IL-10 were 2824.4±90.7, 224.5±4.0, 524.3±4.8, and 143.0±9.5pg/mL, respectively, which were higher than the levels in normal controls. Moreover, GFRB exhibited no cytotoxicity. According to the results of region-selective enzyme hydrolysis, the immune responses against GFRB were elicited by the glycans in the GFRB. These results show the potential of GFRB as a functional therapeutic agent with demonstrable immunostimulatory activity.
许多从植物中获得的自然资源因其作为宿主防御增强剂的用途而受到研究。在本研究中,我们研究了米糠(Oryza sativa)麸质(GFRB)的糖蛋白部分是否可以调节免疫反应,例如 RAW 264.7 巨噬细胞系中一氧化氮(NO)、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1β、IL-6 和 IL-10 的产生。GFRB 含有 65.7%的蛋白质和 7.7%的总糖,通过用 80%(NH4)2SO4处理米糠的水提取物制备,提取率为 4.9%。GFRB 通过 SDS-PAGE 由 5 条不同分子量的带组成,可显着提高 RAW 264.7 鼠巨噬细胞中 NO 的产生,在 100μg/mL 浓度下与正常对照相比约提高 10 倍。在 50μg/mL GFRB 处理的 RAW 264.7 细胞中,释放的各种细胞因子(如 TNF-α、IL-1β、IL-6 和 IL-10)水平分别为 2824.4±90.7、224.5±4.0、524.3±4.8 和 143.0±9.5pg/mL,高于正常对照组。此外,GFRB 没有细胞毒性。根据区域选择性酶水解的结果,GFRB 的免疫反应是由 GFRB 中的糖引发的。这些结果表明 GFRB 作为一种具有明显免疫刺激活性的功能性治疗剂具有潜力。